Deposits of topical norfloxacin in the treatment of bacterial keratitis

Cornea

Volumn 16, Issue 4, 1997, Pages 420-423

  Castillo, Alfredo ^a   Benitez Del Castillo, Jose M ^b   Toledano, Nicolas ^a   Diaz Valle, David ^a   Sayagues, Octavio ^a   Garcia Sanchez, Julian ^b  

^a HOSPITAL DE MÓSTOLES   (Spain)

^b UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

Author keywords

Bacteria; Deposits; Keratitis; Norfloxacin; Quinolone

Indexed keywords

ATROPINE; CIPROFLOXACIN; NORFLOXACIN; OFLOXACIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; TOBRAMYCIN;

AGED; ARTICLE; CASE REPORT; DOSE RESPONSE; DRUG ACCUMULATION; DRUG FORMULATION; FEMALE; HUMAN; KERATITIS; LACRIMAL FLUID; MALE; PRIORITY JOURNAL; SOLUBILITY; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS EPIDERMIDIS; TOPICAL DRUG ADMINISTRATION;

EID: 0342762017     PISSN: 02773740     EISSN: None     Source Type: Journal    
DOI: 10.1097/00003226-199707000-00008     Document Type: Article

References (12)

1. Leibowitz HM. Clinical evaluation of ciprofloxacin 0.3% ophthalmic solution for treatment of bacterial keratitis. Am J Ophthalmol 1991;112:34-47S.
2. Wilhelmus KR, Hyndiuk RA, Caldwell DR, Abshire RL, Folkens AT, Godio LB. 0.3% Ciprofloxacin ophthalmic ointment in the treatment of bacterial keratitis. Arch Ophthalmol 1993;111: 1210-8.
3. Insler MS, Fish LA, Silbernagel J, Hobden JA, O'Callaghan RJ, Hill JM. Succesful treatment of methicillin-resistant Staphylococcus aureus keratitis with topical ciprofloxacin. Ophthalmology 1991;98:1690-2.
4. Parks DJ, Abrams DA, Sarfarazi FA, Katz HR. Comparison of topical ciprofloxacin to conventional antibiotic therapy in the treatment of ulcerative keratitis. Am J Ophthalmol 1993;115:471-7.
5. Reidy JJ, Hobden JA, Hill JM, Forman K, O'Callaghan RJ. The efficacy of topical ciprofloxacin and norfloxacin in the treatment of experimental Pseudomonas keratitis. Cornea 1991;10(1):25-8.
6. Vajpayee RB, Gupta SK, Angra SK, Munjal A. Topical norfloxacin therapy in Pseudomonas corneal ulceration. Cornea 1991;10 (3):268-71.
7. Gritz DC, McDonell PJ, Lee TY, Tang-Liu D, Hubbard BB, Gwon A. Topical ofloxacin in the treatment of Pseudomonas keratitis in a rabbit model. Cornea 1992;11(2):143-7.
8. Gwon A. Ofloxacin vs tobramycin for the treatment of external ocular infection. Arch Ophthalmol 1992;110:1234-7.
9. Mitsui Y, Kitano S, Inagak M. Study on therapeutic effects and optimal concentration of a new synthetic antibacterial agent, ofloxacin eye drops (DE-055) in the treatment of external ocular infections. Jpn Rev Clin Ophthalmol 1985;79:1718-22.
10. Kanellopoulos AJ, Miller F, Wittpen JR. Deposition of topical ciprofloxacin to prevent re-epithelialization of a corneal defect. Am J Ophthalmol 1994;117:258-9.
11. Essepian JP, Rajpal R, O'Brien TP. Tandem scanning confocal microscopic analysis of ciprofloxacin corneal deposits in vivo. Cornea 1995;14(4):402-7.
12. National Committee for Clinical Laboratory Standards 1990. Performance standards for antimicrobial disk susceptibility tests, approved standard M2-A4. 4th ed. Villanova, Pa: NCCLS, 1990.